Asarch A, Gottlieb AB, Lee J et al.
Tufts Medical Center, Boston, MA, USA.
J Am Acad Dermatol 2009;61:104–11.
Editor’s note: A growing number of articles report various cutaneous eruptions in patients receiving tumor necrosis factor-α (TNF-α) inhibitors. Most reports have focused on psoriasiform eruptions; however, other eruptions, such as eczematous dermatitis, a lupus-like syndrome, leukocytoclastic vasculitis, interstitial granulomatous dermatitis, granuloma annulare, acneiform eruptions, and minor skin infections, have also been described.